Tiseo M - Search Results

1

CT-guided biopsy of pulmonary nodules: is pulmonary hemorrhage a complication or an advantage?

De Filippo M, Saba L, Silva M, Zagaria R, Concari G, Nizzoli R, Bozzetti C, Tiseo M, Ardizzoni A, Lipia S, Paladini I, Macarini L, Carrafiello G, Brunese L, Rotondo A, Rossi C. De Filippo M, et al. Among authors: tiseo m. Diagn Interv Radiol. 2014 Sep-Oct;20(5):421-5. doi: 10.5152/dir.2014.14019. Diagn Interv Radiol. 2014. PMID: 25163758 Free PMC article.

2

Epidermal growth factor receptor inhibitors: a new prospective in the treatment of lung cancer.

Tiseo M, Loprevite M, Ardizzoni A. Tiseo M, et al. Curr Med Chem Anticancer Agents. 2004 Mar;4(2):139-48. doi: 10.2174/1568011043482106. Curr Med Chem Anticancer Agents. 2004. PMID: 15032719 Review.

3

Predictors of clinical response of non-small cell cancer to gefitinib.

Ardizzoni A, Tiseo M. Ardizzoni A, et al. Among authors: tiseo m. JAMA. 2004 Apr 7;291(13):1563; author reply 1563-4. doi: 10.1001/jama.291.13.1563-a. JAMA. 2004. PMID: 15069041 No abstract available.

4

Second-line chemotherapy in the treatment of advanced non-small cell lung cancer (NSCLC).

Ardizzoni A, Tiseo M. Ardizzoni A, et al. Among authors: tiseo m. J Chemother. 2004 Nov;16 Suppl 4:104-7. doi: 10.1179/joc.2004.16.Supplement-1.104. J Chemother. 2004. PMID: 15688623 Review.

5

Platinum-based versus non-platinum-based chemotherapy in advanced non-small-cell lung cancer: does cisplatin versus carboplatin make a difference?

Tiseo M, Boni L, Ardizzoni A. Tiseo M, et al. J Clin Oncol. 2005 Sep 1;23(25):6276-7; author reply 6277-8. doi: 10.1200/JCO.2005.02.0156. J Clin Oncol. 2005. PMID: 16135504 No abstract available.

6

Multi-target inhibitors in non-small cell lung cancer (NSCLC).

Tiseo M, Franciosi V, Ardizzoni A. Tiseo M, et al. Ann Oncol. 2006 Mar;17 Suppl 2:ii55-57. doi: 10.1093/annonc/mdj924. Ann Oncol. 2006. PMID: 16608985 Free article. Review. No abstract available.

7

Novel targeted approaches in non-small cell lung cancer (NSCLC).

Ardizzoni A, Tiseo M. Ardizzoni A, et al. Among authors: tiseo m. Ann Oncol. 2006 May;17 Suppl 5:v91-3. doi: 10.1093/annonc/mdj959. Ann Oncol. 2006. PMID: 16807473 Free article. Review. No abstract available.

8

Decline in serum carcinoembryonic antigen and cytokeratin 19 fragment during chemotherapy predicts objective response and survival in patients with advanced nonsmall cell lung cancer.

Ardizzoni A, Cafferata MA, Tiseo M, Filiberti R, Marroni P, Grossi F, Paganuzzi M. Ardizzoni A, et al. Among authors: tiseo m. Cancer. 2006 Dec 15;107(12):2842-9. doi: 10.1002/cncr.22330. Cancer. 2006. PMID: 17103443 Free article.

9

Combination of target agents: challenges and opportunities.

Ardizzoni A, Tiseo M. Ardizzoni A, et al. Among authors: tiseo m. J Thorac Oncol. 2007 May;2(5 Suppl):S4-6. doi: 10.1097/01.JTO.0000268632.79906.c3. J Thorac Oncol. 2007. PMID: 17457232 Free article. Review. No abstract available.

10

Short hydration regimen and nephrotoxicity of intermediate to high-dose cisplatin-based chemotherapy for outpatient treatment in lung cancer and mesothelioma.

Tiseo M, Martelli O, Mancuso A, Sormani MP, Bruzzi P, Di Salvia R, De Marinis F, Ardizzoni A. Tiseo M, et al. Tumori. 2007 Mar-Apr;93(2):138-44. doi: 10.1177/030089160709300205. Tumori. 2007. PMID: 17557559

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

384 results

Search Page

Filters